Ablexis Announces License Agreement with Adimab
Ablexis grants rights for Adimab to internalize select strains of the AlivaMab® Mouse platform for antibody drug discovery for its clientsSAN DIEGO--(BUSINESS WIRE)--Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agr...
Larry Green Eric Krauland Alivamab Discovery Services Alivamab Mouse Chief Executive Officer Mab Mouse
Source: pharmiweb.com